| Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand ... - Reuters |
|
|
ReutersThe report also finds that although surveyed nephrologists have an overall conservative attitude towards biosimilar use, they are not completely opposed to ... read more |